Neurofibromatosis treatment with immunotherapy

Conventional treatment is not always possible for neurofibromatosis, such as tumors affecting the brain or other hard-to-reach organs. Given this, immune drugs can be effective in treating NF type 1. In addition, the therapy can prevent severe hearing damage associated with radiotherapy, which treats tumors associated with NF type 2. Before starting treatment, doctors conduct several tests to check whether the therapy will be effective in your case. If the result is positive, the physician will prescribe the most suitable drug to help your immune system fight against the disease. About half of the slow-growing tumors contain many T-cells, which can destroy the mass. These tumors with "high immunity" are good candidates for immunotherapy treatment. The therapy course is carried out on an outpatient basis. Some immunotherapies are given in cycles. Therefore, you can receive treatment every couple of weeks or once a month. Depending on the individual tumor characteristics, doctors use such medications as bevacizumab and many others. In addition, patients can expect tumors to slow the growth or reduce in size. This approach helps cope with symptoms, preserve vital functions, or prepare for surgery to remove the mass.